GENERAL ATLANTIC, L.P. - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 116 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GENERAL ATLANTIC, L.P. ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q3 2023$67,760,000
+41.2%
4,000,0000.0%1.05%
+38.2%
Q2 2023$48,000,000
-7.8%
4,000,0000.0%0.76%
+25.1%
Q1 2023$52,080,000
-11.9%
4,000,0000.0%0.60%
-22.6%
Q4 2022$59,120,000
+66.8%
4,000,0000.0%0.78%
+87.5%
Q3 2022$35,440,000
-29.9%
4,000,0000.0%0.42%
-36.8%
Q2 2022$50,560,000
-33.2%
4,000,0000.0%0.66%
-4.6%
Q1 2022$75,680,000
-46.1%
4,000,0000.0%0.69%
-36.1%
Q4 2021$140,320,000
-4.2%
4,000,0000.0%1.08%
+26.4%
Q3 2021$146,440,0004,000,0000.86%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders